Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in women can be caused by genetics, menopause, certain health conditions, and emotional stress, and it often results in thinner hair and a changing hairline.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Hydroxychloroquine can help treat certain types of hair loss.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

Many women with hair loss also have zinc deficiency, iron depletion, or thyroid issues.

Some women with common hair loss may develop permanent hair loss.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

High testosterone increases heart disease risk in women with PCOS.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Topical finasteride works faster and better than 17α-estradiol for postmenopausal hair loss.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

A rare case of a woman having both lichen planus pigmentosus and classic lichen planopilaris at the same time.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

A 46-year-old man showed symptoms of a rare condition usually seen in postmenopausal women, highlighting the need for dentist-dermatologist collaboration.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Pregnant women often experience skin and hair changes, with over half getting stretch marks and pigment changes, and should be cautious with cosmetic procedures due to potential risks.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Effective treatment for midlife women's hair loss is limited, with 5% minoxidil foam being the only proven option for the most common type.

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.